ClinicalMind, LLC, a premier and award-winning healthcare communications company, announced that it has acquired IC Axon, a leader in developing science-driven training for pharmaceutical and life science companies. The acquisition will enhance the opportunities for greater strategic and tactical offerings of both companies for their pharmaceutical and biotech clients.
Recommended AI News: ADT Invests in Percepta Labs, “Ethical AI” Security Technology Startup
IC Axon was founded in 1995 and is headquartered in Montreal, Canada. IC Axon designs and deploys customized clinical and sales training solutions for clients worldwide. The company includes a large team of in-house clinical experts, including medical writers, editors, and dedicated referencing systems managers. They have been recognized as leaders in the field with more than 75 industry awards for their focused instructional and blended learning solutions using a variety of digital platforms, as well as their excellent visual communications.
“IC Axon brings a unique blend of learning and development expertise to the ClinicalMind family of companies,” said Jeanne Martel, CEO of CM. “We are excited to now offer our clients the expanded capabilities of IC Axon’s digital learning strategies and training approaches for the benefit of new sales and clinical field teams.”
Recommended AI News: ServiceNow Delivers New Native Workflows in Microsoft Teams to Power the Future of Work
“The opportunity to join forces with a like-minded, scientifically driven organization like ClinicalMind is extremely exciting,” said Rob Charasidis, General Manager of IC Axon. “We have found that culturally and in terms of business goals, IC Axon and ClinicalMind are well aligned and will be a value-added strategic partnership for all our customers.”
Recommended AI News: Legendary Ventures Invests In SpaceX
Comments are closed, but trackbacks and pingbacks are open.